04 May Report for Monitoring and Advertising of Promotional Material
The Regulatory Compliance Unit of the South African Health Products Regulatory Authority (SAHPRA) is mandated to ensure that the marketing and promotion of medicines, scheduled substances, medical devices, and in vitro diagnostic medical devices (IVDs), for both human and veterinary use, comply with the Medicines Act and its General Regulations. Effective oversight of advertising and promotional practices is critical, as misleading or inappropriate promotion can lead to irrational or incorrect use of medical products. Providing accurate, scientifically substantiated, and reliable information is essential for the protection of public health, particularly in light of the diverse levels of medical understanding within the population. Accordingly, the marketing and advertising of medical products must be strictly controlled and consistently aligned with the legislative framework established by the Medicines Act and its Regulations.